1 |
Lai R, Crevier L, Thabane L (2005). Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 1784-90.
DOI
|
2 |
Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
3 |
Norppa H (2004). Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett, 149, 309-34.
DOI
|
4 |
Pinarbasi H, Silig Y, Gurelik M (2005). Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genet Cytogenet, 156, 144-9.
DOI
|
5 |
Schwartzbaum JA, Ahlbom A, Lonn S, et al (2007). An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev, 16, 559-65.
DOI
|
6 |
Trizna Z, De Andrade M, Kyritsis AP, et al (1998). Genetic polymorphisms in glutathione S-transferase (mu) and (theta), N- acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiology Biomarkers and Prevention, 7, 553-5.
|
7 |
Wrensch M, Kelsey KT, Liu M, et al (2004). Glutathione-Stransferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev, 13, 461-7.
|
8 |
De Roos AJ, Rothman N, Inskip PD, et al (2003). Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev, 12, 14-22.
|
9 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
|
10 |
Elexpuru-Camiruaga J, Buxton N, Kandula V, et al (1995). Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res, 55, 4237-9.
|
11 |
Ezer R, Alonso M, Pereira E, et al (2002). Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol, 59, 123-34.
DOI
|
12 |
Fisher JL, Schwartzbaum JA, Wrensch M, et al (2007). Epidemiology of brain tumors. Neurol Clin, 25, 867-90.
DOI
|
13 |
Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
DOI
|
14 |
Hayes JD, Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology, 61, 154-66.
DOI
|
15 |
Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
DOI
|
16 |
Inskip PD, Linet MS, Heineman EF (1995). Etiology of brain tumors in adults. Epidemiol Rev, 17, 382-414.
DOI
|
17 |
Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
DOI
|
18 |
Kondratieva TV, Imyanitov EN, Togo AV, et al (2000). L-MYC and GSTM1 polymorphisms are associated with unfavourable clinical parameters of gliomas. J Exp Clin Cancer Res, 19, 197-200.
|
19 |
Coles BF, Kadlubar FF (2003). Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors, 17, 115-30.
DOI
|
20 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
|
21 |
Custodio AC, Almeida LO, Pinto GR, et al (2010). GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res, 9, 2328-34.
DOI
|